MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
30.5 M |
Market Cap[1] |
$ 64.6 M |
EBITDA (LTM) |
$ -54 M |
P/E (LTM) |
-1.47651 |
P/S (LTM) |
- |
EPS (LTM) |
-1.49 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
IMARA
IMRA
|
- | 15.96 % | $ 663 M | Nasdaq Global Select Market | USA |
 |
KalVista Pharmaceuticals
KALV
|
- | - | $ 1.45 B | Nasdaq Global Select Market |  Britain |
 |
KemPharm
KMPH
|
- | -0.34 % | $ 200 M | Nasdaq Capital Market | USA |
 |
Kezar Life Sciences
KZR
|
- | - | $ 53.3 M | Nasdaq Global Select Market | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
- | - | $ 63.4 M | Nasdaq Capital Market | USA |
 |
Magenta Therapeutics
MGTA
|
- | -7.74 % | $ 41.6 M | Nasdaq Global Select Market | USA |
 |
NovaBay Pharmaceuticals
NBY
|
- | - | $ 11.3 M | NYSE American | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
- | 0.43 % | $ 12 M | Nasdaq Global Select Market | USA |
 |
OncoCyte Corporation
OCX
|
- | 17.22 % | $ 355 K | NYSE American | USA |
 |
Onconova Therapeutics
ONTX
|
- | -0.47 % | $ 21 M | Nasdaq Capital Market | USA |
 |
Opthea Limited
OPT
|
- | - | $ 1.2 B | Nasdaq Global Select Market |  Australia |
|
BiomX
PHGE
|
$ 1.85 | 14.2 % | $ 3.02 M | NYSE American |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
- | -15.58 % | $ 1.22 B | Nasdaq Capital Market |  Germany |
 |
Plus Therapeutics
PSTV
|
- | - | $ 301 M | Nasdaq Capital Market | USA |
 |
Pluristem Therapeutics
PSTI
|
- | -1.9 % | $ 33.3 M | Nasdaq Global Select Market | Israel |
 |
Qualigen Therapeutics
QLGN
|
- | 5.59 % | $ 1.16 M | Nasdaq Global Select Market | USA |
|
Qilian International Holding Group Limited
QLI
|
- | -6.08 % | $ 184 M | Nasdaq Global Select Market |  China |
 |
Cassava Sciences
SAVA
|
- | - | $ 110 M | Nasdaq Capital Market,SPB | USA |
 |
Selecta Biosciences
SELB
|
- | -8.69 % | $ 126 M | Nasdaq Global Market | USA |
 |
Sangamo Therapeutics
SGMO
|
- | - | $ 50.4 M | Nasdaq Global Select Market | USA |
 |
Salarius Pharmaceuticals
SLRX
|
- | - | $ 2.64 M | Nasdaq Global Select Market | USA |
 |
Sensei Biotherapeutics
SNSE
|
- | - | $ 17.5 M | Nasdaq Global Market | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
- | - | $ 826 K | Nasdaq Global Select Market | USA |
 |
Synthetic Biologics
SYN
|
- | 1.32 % | $ 16.2 M | NYSE American | USA |
 |
Synlogic
SYBX
|
- | - | $ 7.07 M | Nasdaq Global Market | USA |
 |
Virios Therapeutics, LLC
VIRI
|
- | 2710.01 % | $ 72.9 M | Nasdaq Capital Market | USA |
 |
Vallon Pharmaceuticals
VLON
|
- | -6.47 % | $ 5.76 M | Nasdaq Global Select Market | USA |
 |
Vaxart
VXRT
|
- | -25.06 % | $ 46.3 M | Nasdaq Capital Market,SPB | USA |
 |
XOMA Corporation
XOMA
|
- | - | $ 485 M | Nasdaq Global Select Market | USA |
 |
Repare Therapeutics
RPTX
|
- | - | $ 112 M | Nasdaq Global Select Market |  Canada |
 |
Sesen Bio
SESN
|
- | 7.29 % | $ 127 M | Nasdaq Global Select Market | USA |
|
Windtree Therapeutics
WINT
|
- | - | $ 26.8 M | Nasdaq Global Select Market | USA |
 |
Trean Insurance Group
TIG
|
- | - | $ 316 M | Nasdaq Global Select Market | USA |
 |
SQZ Biotechnologies Company
SQZ
|
- | 57.95 % | $ 12.8 M | NYSE | USA |
 |
MEI Pharma
MEIP
|
- | 10.43 % | $ 20.5 M | Nasdaq Capital Market | USA |
 |
Palatin Technologies
PTN
|
- | - | $ 13 M | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
ММЦБ
GEMA
|
- | - | - | MOEX | Russia |
 |
Lyra Therapeutics
LYRA
|
- | - | $ 24.9 M | Nasdaq Global Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
ОЗОН Фармацевтика
OZPH
|
- | - | - | MOEX | Russia |
 |
Промомед
PRMD
|
- | - | - | MOEX | Russia |
 |
Brickell Biotech
BBI
|
- | -5.38 % | $ 6.06 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
ESSA Pharma
EPIX
|
- | - | $ 8.86 M | Nasdaq Capital Market | Canada |
 |
Generation Bio Co.
GBIO
|
- | - | $ 344 M | Nasdaq Global Select Market | USA |
 |
Clearside Biomedical
CLSD
|
- | - | $ 25.3 M | Nasdaq Global Market | USA |
 |
Merus N.V.
MRUS
|
- | - | $ 5.78 B | Nasdaq Global Select Market |  Niderland |
 |
RAPT Therapeutics
RAPT
|
- | - | $ 2.36 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.